Clinical Trials Browser

Leiomyoma

NCT05161195 2026-02-02

Roll-over Study to Allow Continued Access to Ribociclib

Phase 4 Active not recruiting

134 enrolled

Breast

Breast Neoplasms

NCT05206448 2025-04-15

CLC II

Phase 4 Active not recruiting

190 enrolled 15 charts

Infertility, Polycystic Ovary Syndrome

NCT02661932 2025-01-31

Brovale

Phase 4 Completed

65 enrolled

Breast

Breast Neoplasms

NCT05168865 2024-02-20

Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.

Phase 4 Withdrawn

Abortion, Spontaneous, Polycystic Ovary Syndrome

NCT05809024 2023-04-12

Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

Phase 4 Recruiting

100 enrolled

Breast

Locally Advanced Breast Cancer

NCT03948568 2022-09-30

REaCT-RETT

Phase 4 Completed

262 enrolled

Breast

Breast Neoplasms

NCT02679755 2022-07-27

Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer

Phase 4 Completed

252 enrolled 15 charts

Breast

Breast Neoplasms

NCT01999569 2022-04-22

The Role of Estrogen in Luteinizing Hormone Surge and Ovulation

Phase 4 Completed

10 enrolled 7 charts

Gynecologic

Ovarian Cysts

NCT04069117 2022-04-06

Follicular Synchronization in PCOS Patients Undergoing ICSI

Phase 4 Completed

200 enrolled

Polycystic Ovary Syndrome

NCT03220178 2022-01-06

PRECYCLE

Phase 4 Terminated

532 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04137640 2021-07-20

Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy

Phase 4 Not yet recruiting

152 enrolled

Breast

Breast Neoplasms

NCT00688909 2021-06-09

REAL

Phase 4 Completed

261 enrolled 13 charts

Breast

Breast Neoplasms

NCT04002635 2021-01-08

LEFT

Phase 4 Withdrawn

Infertility, Female, Polycystic Ovary Syndrome

NCT02470741 2019-11-15

PLUM

Phase 4 Completed

12 enrolled 7 charts

Leiomyoma

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT01612871 2018-03-05

MIRHO

Phase 4 Completed

39 enrolled

Breast

Breast Neoplasms

NCT01127295 2018-03-02

PHACS

Phase 4 Completed

2,000 enrolled

Breast

Breast Neoplasms

NCT00237133 2017-02-24

PREDICT

Phase 4 Completed

112 enrolled

Breast

Breast Neoplasms

NCT00478504 2016-10-28

Letrozole Versus Clomifene Citrate for Ovulation Induction

Phase 4 Completed

159 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT01908556 2013-07-25

PreFace

Phase 4 Unknown

3,545 enrolled

Breast

is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.

NCT01553903 2013-06-04

OXYTAM

Phase 4 Completed

29 enrolled

Breast

Breast Neoplasms

NCT00014638 2013-02-21

Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

Phase 4 Completed

Breast

Breast Neoplasms

NCT00241046 2012-04-19

Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment

Phase 4 Terminated

13 enrolled

Breast

Breast Neoplasms

NCT00171847 2010-03-31

eLEcTRA

Phase 4 Terminated

93 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00237224 2009-11-19

Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole

Phase 4 Completed

40 enrolled

Breast

Breast Neoplasms